Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000502729 | SCV000593013 | benign | not specified | 2019-03-20 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000560459 | SCV000656046 | benign | Dyskeratosis congenita, autosomal dominant 6 | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000560459 | SCV002524368 | benign | Dyskeratosis congenita, autosomal dominant 6 | 2021-12-05 | criteria provided, single submitter | clinical testing | |
Center for Genomic Medicine, |
RCV000502729 | SCV002551730 | likely benign | not specified | 2023-08-15 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002358384 | SCV002620294 | likely benign | Inborn genetic diseases | 2022-02-12 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV003419854 | SCV004139987 | likely benign | not provided | 2024-06-01 | criteria provided, single submitter | clinical testing | ACD: BP4, BP7, BS2 |
Breakthrough Genomics, |
RCV003419854 | SCV005251460 | benign | not provided | criteria provided, single submitter | not provided |